Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-19

Clinical Trial Update: Effect of TU-100 in Patients Undergoing Laparoscopic Colectomy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating TU-100 (Daikenchuto) for postoperative ileus after laparoscopic colectomy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TU-100 (Daikenchuto)

Snippet

Sponsor: Tsumura USA | Conditions: Postoperative Ileus | Phase 2 | Status: COMPLETED | Results posted: 2020-06-19